癌症治疗诱导的血小板缺血:诊断,机制和管理
Xutong Zhao1, Xiu Shan1, Shaofeng Sui1
1First Affiliated Hospital, Dalian Medical University, Dalian, China.
Frontiers in immunology
|October 9, 2025
概括
癌症治疗诱导的血小板缺血 (CTIT) 会增加出血的风险. 本综述探讨了如血小板输血和TPO-RAs等当前的治疗方法,以及包括传统中医在内的新策略,以更好地管理CTIT.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症治疗诱导的血小板缺血 (CTIT) 是癌症患者经常出现的并发症,导致出血风险增加.
- CTIT对癌症治疗的有效性和患者的生活质量产生负面影响.
研究的目的:
- 审查CTIT目前的治疗策略.
- 探索包括传统中医药在内的新兴治疗方法,用于管理CTIT.
主要方法:
- 对CTIT现有的治疗方法的文献综述.
- 探索新的治疗途径及其潜在的有效性和安全性.
主要成果:
- 目前的治疗方法,如血小板输血,rhIL-11,rhTPO和TPO-RAs都有局限性和争议.
- 血小板输血带有不良反应的风险.
- rhTPO和TPO-RAs的有效性和安全性仍在争论中.
结论:
- 需要更有效,更安全的CTIT治疗方法.
- 新的治疗方法,可能包括传统中医药,需要进一步调查,以改善CTIT管理.
相关概念视频
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Venous Thrombosis IV: Nursing Management
196
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
196
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


